Market Overview

Benzinga's Top Upgrades

Share:
Related CAH
Benzinga's Top Downgrades
Analyst: Cardinal Health Buying Spree To Boost FY17 EPS
The Vetr community has downgraded $CAH to 4-Stars (Vetr)
Related LLY
Benzinga's Top Initiations
U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent
Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled (Zacks)

Analysts at ISI Group upgraded Cardinal Health (NYSE: CAH) from “hold” to “buy.” Cardinal Health's shares closed at $40.85 yesterday. Cardinal Health's trailing-twelve-month ROE is 17.70%.

Analysts at Goldman Sachs upgraded Eli Lilly & Co (NYSE: LLY) from “sell” to “neutral.” Eli Lilly's shares closed at $50.78 yesterday. Eli Lilly's trailing-twelve-month revenue is $23.40 billion.

Analysts at Citigroup upgraded The Interpublic Group of Companies (NYSE: IPG) from “neutral” to “buy.” Interpublic Group's stock closed at $11.43 yesterday. Interpublic Group's PEG ratio is 1.16.

Analysts at Sterne Agee upgraded Shoe Carnival (NASDAQ: SCVL) from “neutral” to “buy.” Shoe Carnival's shares closed at $22.65 yesterday. Shoe Carnival's trailing-twelve-month operating margin is 5.61%.

Latest Ratings for CAH

DateFirmActionFromTo
Jul 2015Evercore ISIDowngradesBuyHold
Jun 2015Deutsche BankMaintainsHold
Mar 2015FBR CapitalMaintainsOutperform

View More Analyst Ratings for CAH
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CAH + IPG)

View Comments and Join the Discussion!

Get Benzinga's Newsletters